Skip to main content

Market Overview

38 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • RadiSys Corporation (NASDAQ: RSYS) shares climbed 113.2 percent to $1.49 after Reliance Industries announced plans to acquire Radisys for $1.72 per share in cash.
  • New Concept Energy, Inc. (NYSE: GBR) shares jumped 110.3 percent to $8.8752 after climbing 145.33 percent on Friday.
  • Bioanalytical Systems, Inc. (NASDAQ: BASI) surged 46.1 percent to $2.41 on announcement of asset purchase agreement with Seventh Wave Laboratories, LLC.
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 43.5 percent to $4.595 in reaction to a new partnership with Novartis AG (ADR) (NYSE: NVS). Adamis, a specialty biopharmaceutical company that focuses on treatments for respiratory diseases and allergies, said in a press release it entered into an exclusive distribution and commercialization agreement with global health care giant Novartis.
  • ZK International Group Co., Ltd. (NASDAQ: ZKIN) gained 24.7 percent to $3.96.
  • Roadrunner Transportation Systems, Inc. (NASDAQ: RRTS) shares jumped 18.7 percent to $2.4801. Roadrunner posted Q1 loss of $0.61 per share on sales of $570 million.
  • BRF S.A. (NYSE: BRFS) shares rose 14.4 percent to $5.355.
  • BioLife Solutions Inc (NASDAQ: BLFS) gained 14.3 percent to $13.0440 after the company reported a 103 percent rise in its Q2 preliminary revenue and raised 2018 revenue guidance.
  • Energy Fuels Inc. (NYSE: UUUU) shares rose 12.1 percent to $2.5449.
  • Acxiom Corporation (NASDAQ: ACXM) shares climbed 10.9 percent to $33.21. Interpublic is nearing a deal to acquire Acxiom's marketing solutions unit for $2.2 billion, Reuters reported.
  • China Lending Corporation (NASDAQ: CLDC) gained 10.6 percent to $3.33.
  • Dell Technologies Inc. (NYSE: DVMT) rose 9.6 percent to $92.69 after the company announced plans to buy out VMWare tracking stock in a cash and equity deal.
  • Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) gained 9.6 percent to $25.843.
  • Mexco Energy Corporation (NYSE: MXC) climbed 9.4 percent to $6.5501. Mexco Energy posted FY18 loss of $0.16 per share on operating sales of $2.71 million.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 9.2 percent to $7.72. Cantor Fitzgerald initiated coverage on Marinus Pharmaceuticals with an Overweight rating and a $19 price target.
  • Syntel, Inc. (NASDAQ: SYNT) shares jumped 9.1 percent to $35.0168.
  • TDH Holdings, Inc. (NASDAQ: PETZ) rose 8.1 percent to $5.10.
  • Perry Ellis International, Inc. (NASDAQ: PERY) rose 7.2 percent to $29.11 after Randa announced plans to acquire the company for $28 per share.
  • Compugen Ltd. (NASDAQ: CGEN) rose 6.8 percent to $3.525 in reaction to an encouraging FDA update. The clinical-stage cancer immunotherapy company said the FDA cleared its partner Bayer AG's investigational new drug application for BAY 1905254 for patients with advanced solid tumors. As part of a collaboration and license agreement, Compugen and Bayer pursued preclinical research and Compugen is now entitled to receive a milestone payment after completion of the approved phase 1 clinical trial.
  • VMware, Inc. (NYSE: VMW) rose 6.8 percent to $157.01. Dell Technologies announced plans to buy out VMWare tracking stock in a cash and equity deal.
  • PEDEVCO Corp. (NYSE: PED) rose 6.6 percent to $2.420 after the company regained compliance with NYSE American listing standards.
  • Xspand Products Lab, Inc. (NASDAQ: XSPL) rose 4 percent to $8.0772 after the company reported the acquisition of strategic partner, Edison Nation LLC.

 

Check out these big penny stock gainers and losers

Losers

  • MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) dipped 42.3 percent to $0.49 on announcement that company will not attempt to regain NASDAQ listing compliance.
  • MiMedx Group Inc (NASDAQ: MDXG) declined 34.5 percent to $4.185. MiMedx reported the resignation of its Chairman and CEO Parker H. "Pete" Petit. The company also reported that William C. "Bill" Taylor has resigned as President and COO.
  • Nuvectra Corporation (NASDAQ: NVTR) fell 22 percent to $16.02 after the company disclosed that it is still working with the FDA to conclude review for Virtis treatment.
  • Newater Technology, Inc. (NASDAQ: NEWA) shares declined 15.7 percent to $20.15.
  • SuperCom Ltd. (NASDAQ: SPCB) dropped 15 percent to $1.99 after surging 50.97 percent on Friday.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares fell 13.8 percent to $0.2671. Helios And Matheson Analytics disclosed that it has filed a $1.2 billion universal shelf registration statement.
  • Core Laboratories N.V. (NYSE: CLB) fell 12.3 percent to $110.64 after the company issued weak guidance.
  • Domo, Inc. (NASDAQ: DOMO) shares dropped 11.5 percent to $24.15.
  • Atlanticus Holdings Corporation (NASDAQ: ATLC) shares tumbled 10.9 percent to $1.84.
  • Stein Mart, Inc. (NASDAQ: SMRT) fell 10.6 percent to $2.190.
  • Fibrocell Science Inc (NASDAQ: FCSC) slipped 10 percent to $2.435. Fibrocell reported a 1.47 million share registered direct offering priced at-the-market for gross proceeds of $4 million.
  • Nevro Corp. (NASDAQ: NVRO) fell 9.5 percent to $72.30. Morgan Stanley downgraded Nevro from Overweight to Equal-Weight.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares fell 8.8 percent to $6.16.
  • Nano Dimension Ltd. (NASDAQ: NNDM) dipped 8.8 percent to $1.915.
  • Melco Resorts & Entertainment Limited (NASDAQ: MLCO) shares fell 8 percent to $25.78.
  • Dermira, Inc. (NASDAQ: DERM) shares fell 7 percent to $8.56 after gaining 4.78 percent on Friday.
 

Related Articles (ACXM + ADMP)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com